Onyx Pharmaceuticals, Inc. CEO Could Snag $62 Million if He Leaves After Amgen Takeover

Published: Sep 05, 2013

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Onyx Pharmaceuticals Inc. Chairman and CEO Tony Coles will receive more than $62.5 million in severance pay, stock and other benefits, if he loses his job within two years of the company's $10.4 billion sale to Amgen Inc. The figures, laid out in a Securities and Exchange Commission filing Tuesday by the South San Francisco-based cancer drug developer (NASDAQ: ONXX), come less than a week after Onyx told most employees that their stock options would accelerate and vest and that they would receive a minimum of two months base salary, which increases with their job level.

Help employers find you! Check out all the jobs and post your resume.

Back to news